These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16154649)

  • 1. Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle.
    Hiroi R; Neumaier JF
    Behav Brain Res; 2006 Jan; 166(1):93-100. PubMed ID: 16154649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system.
    Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S
    Behav Brain Res; 2009 Mar; 198(1):142-8. PubMed ID: 19046994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCPL delivery system as a model for E + P replacement therapy in post-ovariectomized adult rats mimicking a postmenopausal condition.
    Cason Z; Benghuzzi H; Tucci M; England B
    Biomed Sci Instrum; 2003; 39():529-34. PubMed ID: 12724947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of subchronic doses of 17-beta estradiol in two ethologically based models of anxiety utilizing female rats.
    Koss WA; Gehlert DR; Shekhar A
    Horm Behav; 2004 Aug; 46(2):158-64. PubMed ID: 15256305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Nov; 164(3):318-28. PubMed ID: 12424556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats.
    Frye CA; Walf AA
    Behav Neurosci; 2004 Apr; 118(2):306-13. PubMed ID: 15113256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buspirone and alprazolam treatment on the startle-potentiated startle response.
    Commissaris RL; Fomum EA; Leavell BJ
    Depress Anxiety; 2004; 19(3):146-51. PubMed ID: 15129416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepines have no effect on fear-potentiated startle in humans.
    Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
    Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide involvement in estrous cycle-dependent changes of the behavioral responses of female rats in the elevated plus-maze test.
    Sadeghipour HR; Ghasemi M; Sadeghipour H; Riazi K; Soufiabadi M; Fallahi N; Dehpour AR
    Behav Brain Res; 2007 Mar; 178(1):10-7. PubMed ID: 17207542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenic treatments do not increase fear-potentiated startle in mice.
    Risbrough VB; Geyer MA
    Biol Psychiatry; 2005 Jan; 57(1):33-43. PubMed ID: 15607298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive experience alters anxiety-like behavior in the female rat.
    Byrnes EM; Bridges RS
    Horm Behav; 2006 Jun; 50(1):70-6. PubMed ID: 16524576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress.
    Adamec R; Strasser K; Blundell J; Burton P; McKay DW
    Behav Brain Res; 2006 Feb; 167(2):270-86. PubMed ID: 16256211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the acute and chronic estrogen on anxiety in the elevated T-maze.
    Kalandakanond-Thongsong S; Daendee S; Srikiatkhachorn A
    Physiol Behav; 2012 Jan; 105(2):357-63. PubMed ID: 21907223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle.
    de Jongh R; Geyer MA; Olivier B; Groenink L
    Behav Brain Res; 2005 Jun; 161(2):190-6. PubMed ID: 15878207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of estrogen on activity and fear-related behaviors in mice.
    Morgan MA; Pfaff DW
    Horm Behav; 2001 Dec; 40(4):472-82. PubMed ID: 11716576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat ultrasonic vocalization in aversively motivated situations and the role of individual differences in anxiety-related behavior.
    Borta A; Wöhr M; Schwarting RK
    Behav Brain Res; 2006 Jan; 166(2):271-80. PubMed ID: 16213033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fearfulness in a large N/Nih genetically heterogeneous rat stock: differential profiles of timidity and defensive flight in males and females.
    Lopez-Aumatell R; Guitart-Masip M; Vicens-Costa E; Gimenez-Llort L; Valdar W; Johannesson M; Flint J; Tobeña A; Fernandez-Teruel A
    Behav Brain Res; 2008 Mar; 188(1):41-55. PubMed ID: 18079010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
    Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
    Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.